DOROTHY KEBASO: Open Payments
NPI 1730501214 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 17 payments from 9 companies in 2025. Trend: 2023 $458 · 2024 $258 · 2025 $802
Food & beverage: $802
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $422 |
| Janssen Pharmaceuticals, Inc | 3 | $179 |
| E.R. Squibb & Sons, L.L.C. | 1 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Bausch Health US, LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: CAPLYTA, INVEGA SUSTENNA, COBENFY, UZEDY, INGREZZA, APLENZIN, AUSTEDO XR, ARISTADA.
Industry payments across NC — which companies pay providers there.
